TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
World Bank holds Indonesia’s GDP growth forecast for 2021
The bank found that Indonesia lagged behind some Asian countries in its approach to containing the COVID-19 pandemic.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A stage director looks on at the IMF/World Bank Annual Fall Meetings Plenary Session in Washington, DC, on Oct. 18, 2019. (AFP/Andrew Caballero-Reynolds)
T
he World Bank has maintained its forecast for Indonesia’s gross domestic product (GDP) growth for this year as the country lags behind some Asian economies in containing COVID-19 and in trading manufactured goods.
In its March outlook, the Washington-based lender projects Indonesia’s GDP to grow 4.4 percent this year, an unchanged figure from its December outlook.
The forecast stands at the same level as the average growth expected for the East Asia and the Pacific (EAP) region, excluding China and Vietnam.
“Indonesia chose not to fight hard the disease by hurting livelihoods,” World Bank EAP chief economist Aaditya Mattoo told The Jakarta Post in a video interview on Thursday.
“In a way, it had a more accommodative approach to the disease, which made the economic distress in the short run less a shock than in the Philippines, but the long-term prospects were correspondingly less promising than those in Vietnam."
The outlook noted that Indonesia still largely relied on prolonging mobility restrictions, locally called micro-scale public activity restrictions (PPKM Mikro), to contain the pandemic, whereas countries such as China and Vietnam relied on the more effective mass testing and tracing strategy.
Read also: Positivity rate remains high amid drop in testing, recorded cases
